South Korea Passes EU Equivalence Assessment For APIs
The European Commission took four years to evaluate South Korea's regulatory framework for active pharmaceutical ingredients and to conclude that it is in line with EU standards.
You may also be interested in...
Twelve of the top 20 countries that export active pharmaceutical ingredients (APIs) to the EU have confirmed they will issue written confirmations to certify that their consignments comply with EU good manufacturing practices (GMPs) 1.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-two guidance documents have been posted on the tracker since its last update.
A six-month pilot has been launched in the EU to test new processes for multilingual packaging that allows the use of a reduced text on a medicine’s immediate and outer packaging, subject to agreement by member states.